This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
DuPont Announces Launch of Great Stuff Wide Spray Foam Sealant
by Zacks Equity Research
The foam sealant by DD expands to one inch, forming a strong, airtight and weather-resistant seal.
Here's Why You Should Hold Onto DuPont's Stock for Now
by Zacks Equity Research
While DD faces headwinds from soft demand, it gains on its focus on growth through innovation and acquisition as well as productivity actions.
Why Is DuPont de Nemours (DD) Up 0.9% Since Last Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
DuPont (DD) Shares Up 17% in 6 Months: What's Driving the Stock?
by Zacks Equity Research
DuPont (DD) benefits from its innovation-driven investment, productivity actions and strategic acquisitions.
DuPont (DD) Adds Accessories to Simplify ArmorWall Installations
by Zacks Equity Research
The DuPont (DD) ArmorWall System is one of the best-performing and most innovative external wall system solutions available.
Why You Should Retain DuPont (DD) Stock in Your Portfolio
by Zacks Equity Research
While DuPont (DD) faces headwinds from demand weakness in certain markets, it gains on its focus on growth through innovation and acquisition as well as productivity actions.
Is VanEck Morningstar SMID Moat ETF (SMOT) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SMOT
Are Basic Materials Stocks Lagging Balchem (BCPC) This Year?
by Zacks Equity Research
Here is how Blachem (BCPC) and DuPont de Nemours (DD) have performed compared to their sector so far this year.
Deciphering DuPont de Nemours (DD) International Revenue Trends
by Zacks Equity Research
Examine DuPont de Nemours' (DD) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Why DuPont de Nemours (DD) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DuPont de Nemours (DD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for DuPont de Nemours (DD) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
DuPont's (DD) Earnings and Revenues Top Estimates in Q2
by Zacks Equity Research
DuPont's (DD) earnings and sales surpass estimates in the second quarter on increased volumes.
DuPont de Nemours (DD) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 14.12% and 4.45%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Stay Ahead of the Game With DuPont de Nemours (DD) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of DuPont de Nemours (DD) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
DuPont (DD) Warms Up to Q2 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont is expected to have benefited from its innovation-driven investment and productivity actions amid demand weakness in specific businesses in Q2.
Tronox (TROX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Tronox (TROX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DuPont de Nemours (DD) Reports Next Week: What to Expect
by Zacks Equity Research
DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Chemical Stocks Set to Pull Off a Beat This Earnings Season
by Anindya Barman
DuPont (DD), Eastman Chemical (EMN), Avient (AVNT) and Westlake (WLK) are likely to have benefited from cost and pricing actions as well as improved end-market demand on a moderation of de-stocking activities in Q2.
Want Better Returns? Don?t Ignore These 2 Basic Materials Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Will DuPont de Nemours (DD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DuPont (DD) Tyvek Richmond Facility Gets ISCC+ Certification
by Zacks Equity Research
DuPont's (DD) global integration of ISCC PLUS certification into Tyvek production coincides with the company's commitment to empowering clients on their road to net zero emissions.
Why You Should Retain DuPont (DD) Stock in Your Portfolio
by Zacks Equity Research
While DuPont (DD) faces headwinds from soft demand in certain markets, it benefits from its focus on growth through innovation, the Spectrum Plastics acquisition and productivity actions.
DuPont (DD) to Feature Kalrez Solutions at SEMICON West 2024
by Zacks Equity Research
DuPont's (DD) Kalrez perfluoroelastomer parts portfolio comprises O-rings, custom-designed components and bonded parts that incorporate metals, glass, ceramics and fibers.
Top Research Reports for NVIDIA, Amazon.com & UnitedHealth
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Amazon.com, Inc. (AMZN) and UnitedHealth Group Incorporated (UNH).
DuPont (DD) Acquires Donatelle Plastics, Boosts Medical Portfolio
by Zacks Equity Research
DuPont (DD) announces an agreement to acquire Donatelle Plastics, enhancing its expertise in medical devices and expanding its healthcare solutions portfolio.